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PURPOSE: To evaluate the feasibility of using the Statistical Parametric Mapping (SPM) program for an automated, voxel-by-
voxel assessment of regional cerebral blood flow (rCBF) deficits in Alzheimer’s disease (AD) subjects relative to age-matched
controls studied with a conventional, single-detector SPECT system.
METHODS: We used a databank of 99mTc-HMPAO images of 19 patients with a diagnosis of probable AD and 15 elderly healthy
volunteers; data were acquired using an Orbiter-Siemens single-detector SPECT system. Using SPM, images were transformed
spatially, smoothed (12mm), and the data were compared on a voxel-by-voxel basis with t-tests.
RESULTS: There were significant rCBF reductions in AD patients relative to controls involving regions predicted a priori to be
affected in AD, namely the left temporal and parietal neocortices, and the right posterior cingulate gyrus (p<0.05, corrected for
multiple comparisons).
DISCUSSION: The location of rCBF reductions in AD subjects in our study is consistent with the deficits detected in previous
functional imaging studies of AD using higher-resolution devices. This suggests the potential usefulness of using SPM for the
analysis of data acquired with single-detector SPECT systems, despite the limited sensitivity and spatial resolution of such
equipment.
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INTRODUCTION
Using the techniques of positron emission tomography
(PET), single photon emission computed tomography
(SPECT) and functional magnetic resonance imaging
(MRI); it is now possible to acquire images of high ana-
tomical resolution showing patterns of functional brain ac-
tivity or neurotransmission in vivo.
Several studies using the above functional imaging tech-
niques have compared groups of patients with Alzheimer’s
disease (AD) with healthy controls, most often measuring
resting regional cerebral blood flow (rCBF) or regional
brain glucose metabolism.1,2,3,4 A pattern of hypoactivity in
the temporal and parietal neocortices in association with
AD has been the most characteristic finding in those stud-
ies, detected either by visual inspection or by conventional
quantitative analyses using regions of interest (ROI).
Lately, automated methods have been developed for the
analysis of functional imaging research data, allowing the
comparison of rCBF values between different groups to be
performed on a voxel-by-voxel basis. The most disseminated
method for such purpose is the Statistical Parametric Map-
ping (SPM) program.5 Recent PET and SPECT studies us-
ing SPM-based image analysis methods have replicated the
above findings of temporo-parietal neocortical hypoactivity
in AD; moreover, these studies have been able to document
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resting activity decrements also in the medial temporal re-
gion (where the neuropathological process that characterizes
AD occurs first and with greatest severity), as well as in the
posterior cingulate gyrus and precuneus.6 The involvement
of the posterior cingulate gyrus and precuneus has been de-
tected even in very early stages of AD,6,7,8 as well as in sub-
jects at genetic risk for the disorder.9
SPECT studies of AD using the SPM approach have
been invariably restricted to research centers that have ac-
cess to sophisticated SPECT devices of two or more de-
tectors, using imaging protocols of superior spatial resolu-
tion.10,11 Conventional, single-detector SPECT systems pro-
vide rCBF data of lower spatial resolution and sensitivity
compared to multiple-detector systems, but are cheaper and
more largely available, particularly in routine clinical serv-
ices. However, it is not known whether single-detector
SPECT systems can detect statistically significant rCBF
deficits with the SPM approach in studies comparing AD
samples to healthy controls. In the present study, we de-
scribe the application of the SPM methodology for the
analysis of rCBF data acquired in our Institution with a con-
ventional, single-detector SPECT system, in a group of AD
patients compared to an age- and gender-matched healthy
control group. Our goal was to evaluate the feasibility of
using the SPM program for the analysis of rCBF data ac-
quired with conventional SPECT devices, largely available
in Brazil, attempting to replicate findings of regional




We used a dataset of rCBF SPECT images previously
acquired from a group of 19 patients with probable AD
(mean age = 74.63 years, SD=7.10, 7 males/12 females),
recruited from the “Projeto Terceira Idade” (PROTER), In-
stitute of Psychiatry, under the coordination of one of the
authors (C.M.C.B.). Images were acquired following ap-
proval by the local ethics committee, and after subjects/
relatives gave written informed consent; detailed explana-
tions of the procedures involved were spelt out to each sub-
ject/relative.
The diagnosis of probable AD was made according to
the criteria of the “National Institute of Neurological and
Communicative Disorders/Stroke and Alzheimer’s Disease
and Related Disorders Association of the USA (NINCDS/
ADRDA),12 with basis on a semi-structured interview us-
ing the Cambridge Mental Disorders of the Elderly Exami-
nation (CAMDEX).13 Physical and neurological examina-
tion was also performed in all subjects, as well as blood
screening, urine testing and computed tomography or struc-
tural MRI scanning, with the purpose of excluding other
causes of dementia, as well as general medical conditions
and neurological disorders that could affect brain structure
and/or functioning. The severity of cognitive decline in AD
patients was evaluated using the Mini-Mental State Exami-
nation (MMSE),14 with mean scores of 15.0 (DP= 8.9); this
indicated a mean degree of dementia severity in the mod-
erate range in the AD sample as a whole. The control group
included rCBF SPECT images of 15 elderly healthy vol-
unteers (mean = 71.60 years, SD= 3.85, 4 males/11 fe-
males). There were no significant differences between AD
patients and controls either in regard to their mean age (t=
1.49, p=0.147) or gender distribution (p= 0.72). There were
neither differences between AD patients and controls in re-
gard to their mean number of years of education (mean =
6.21 years, SD= 4.06 and mean = 6.40 years, SD= 3.72
respectively, t=-0.14, p=0.89). All control subjects were in-
terviewed through CAMDEX in order to exclude the pres-
ence of significant cognitive impairment and the presence
of depressive symptoms. We also excluded from the con-
trol group any subjects with a history of current use of
CNS-acting drugs. All subjects in the healthy control group
had MMSE scores greater than 26.
SPECT image acquisition
Images were acquired after intravenous injection of
740MBq technetium-99m hexamethylpropylene-amine-
oxime (99mTc-HMPAO) at rest (eyes closed and ears
plugged). A single-detector SPECT system (Orbiter-Sie-
mens) was used, equipped with low energy high-resolution
(LEHR) collimators. A total of 128 projections was ac-
quired on a 128x128 matrix (70,000 counts per projection).
Images were reconstructed as 1-pixel (3.326mm) thick,
transaxial slices, parallel to the orbitomeatal line, using the
Filtered Back Projection method, after pre-filtering
(Butterworth filter, cut-off frequency 0.35 cycles/pixel and
order 7). We did not apply corrections for scatter and pho-
ton attenuation, given that we privileged the evaluation of
cortical regions previously shown to be affected in the early
stages of AD, rather than subcortical brain structures.
SPECT image processing
SPECT image analysis was performed using the SPM
program,15 version 2002 (SPM2). Initially, this package spa-
tially transforms the images, in order to make them com-
patible with an anatomical template that approximates the
stereotaxic space of the Tailairach and Tornoux atlas16. After
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such spatial transformations, each voxel in all images will
have the same coordinates in the x, y and z axes, corre-
sponding approximately to the Talairach and Tornoux co-
ordinates16. A customized SPECT template was created spe-
cifically for the present study, consisting of a mean image
of all subjects. This strategy was aimed to match the tem-
plate more closely to the population under investigation and
the image acquisition protocols used.17 In order to build this
template, the original SPECT images were spatially trans-
formed to the standard SPM SPECT template, based on the
Montreal Neurological Institute (MNI) template.18 Such a
spatial normalization step was restricted to linear 12-pa-
rameter affine transformations, in order to minimize defor-
mations of the original images. Subsequently, images were
smoothed with an isotropic Gaussian kernel (12 mm
FWHM), and averaged to provide the mean SPECT image
in stereotactic MNI space.
The processing of the original images from all AD pa-
tients and controls was then carried out, beginning by spa-
tial transformations of images to our study-specific SPECT
template, with 12-parameter linear as well as nonlinear
(3x4x3 basis functions) transformations. Spatially normal-
ized images were then re-sliced using tri-linear interpola-
tion to a final voxel size of 2x2x2 mm3, and smoothed us-
ing a 12-mm Gaussian kernel.
Statistical analysis using the SPM program
Voxel-based comparisons of regional tracer uptake val-
ues between AD patients and healthy controls were per-
formed using unpaired t-tests. With the purpose of account-
ing for inter-individual differences in global cerebral blood
flow, the regional 99mTc-HMPAO uptake was standardized
to the mean global uptake using proportional scaling. The
measure of total brain radioactive uptake was obtained au-
tomatically by the SPM program, given by the mean counts
of all voxels included in the SPECT volume of each sub-
ject, after the spatial transformations described above.
In order to reduce the number of statistical compari-
sons, only voxels with signal intensities above 50% of the
mean global value were entered in the group comparisons.
Resulting statistics were transformed to Z-scores,
thresholded at Z=2.33 (corresponding to the p<0.01, sin-
gle-tail), and displayed as statistical parametric maps
(SPMs) into standard space. Firstly, we inspected the re-
sulting SPMs to search for the presence of voxel clusters
of significantly reduced rCBF in the AD group in brain ar-
eas that usually present functional deficits early during the
course of the illness, including: the medial temporal region,
the lateral temporal and parietal neocortices, the medial
parietal cortex (precuneus) and the posterior cingulate
gyrus.6 The voxels mapped to each of those brain regions
were circumscribed using the small volume correction
(SVC) tool available in the SPM package, whereby we ap-
plied predefined, spatially normalized volumes of interest
on the SPMs, resulting in search volumes of: (a) 2,130
voxels for the medial temporal region (encompassing the
hippocampus, parahippocampal gyrus and amygdala); (b)
6,237 voxels for the lateral temporal neocortex (including
the superior, middle, inferior and transverse temporal gyri,
and the insula); (c) 6,941 voxels for the lateral parietal neo-
cortex (encompassing the superior parietal, inferior pari-
etal, angular and supramarginal gyri.); (d) 4,942 voxels for
the posterior cingulate gyrus; and (e) 3,528 voxels for the
medial parietal cortex. Any rCBF differences within those
areas were reported as significant only if surviving correc-
tion for multiple comparisons (p<0.05); such correction was
calculated using the two methods that have been validated
for SPM-based rCBF PET or SPECT studies,15 namely:
(i) correction at the level of cluster of contiguous voxels,
which is based on Gaussian random field theory; and
(ii) the family-wise error (FWE) correction at the voxel
level. Subsequently, we described the presence of rCBF ab-
normalities in other, unpredicted regions; findings in these
additional areas would only be reported as significant if sur-
viving correction for multiple comparisons over the whole
brain (search volume of approximately 274,135 voxels). In
every analysis, we converted MNI coordinates of voxels of
maximal statistical significance to the Talairach and
Tournoux system.16,19
RESULTS
The statistical parametric map showing the foci of sig-
nificant rCBF reductions in AD patients relative to controls,
using the global normalization method, is shown in Figure
1. Using the SVC tool, we detected areas of significantly
reduced activity in the following brain regions predicted a
priori to be affected in AD: the left lateral temporo-pari-
etal necortices, and the right posterior cingulate gyrus
(p<0.05, corrected multiple comparisons). Information on
the level of statistical significance and extent of these foci
is given in Table 1. There were other clusters of between-
group difference located in additional brain regions where
functional deficits had been predicted a priori, namely the
left medial temporal region, the left posterior cingulate cor-
tex and the left precuneus; however, these clusters did not
retain statistical significance after correction for multiple
comparisons (Table 1).
In the statistical map investigating significant rCBF in-
creases in AD patients relative to healthy controls, there
were two unexpected foci of significant hyperactivity, lo-
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Table 1 – Areas of significantly reduced rCBF in subjects with AD (n=19) compared to healthy volunteers (n=15)
Regions + investigated Side§ Coordinates* Brain structure of maximal Peak£ Number# P value$ P value$$
x y z significant  difference within Z-Score of voxels (cluster (voxel
each region (BA) level) level)
Medial temporal lobe Left -18 -13 -22 Parahippocampal gyrus (BA 35) 2.47 51 NS NS
Lateral temporal Left -43  -7  -4 Insula (BA 13) 3.31 882 0.04 NS
neocortex
Lateral parietal Left -43 -60 18 Middle temporal gyrus (BA 39) 3.16 932 0.04 NS
neocortex
Cingulate gyrus Left -11 -52 16 Posterior cingulate cortex (BA 30) 2.90 418 NS NS
Right  10 -40 24 Posterior cingulate cortex (BA 23) 3.63 617 0.04 0.01
Medial parietal cortex Left -13 -54 18 Precuneus (BA 31) 2.93 197 NS NS
+ Brain regions where hypoactivity in the AD group was predicted a priori, circumscribed using the small volume correction (SVC) tool available in the
SPM package.
§ Brain hemisphere where group differences were identified.
* Talairach and Tornoux16 coordinates of the voxel of maximal statistical significance within each area investigated.
£ Z-score for the voxel of maximal statistical significance in each region.
# Total number of contiguous voxels in each region that surpassed the initial cutoff of Z> 2.33.
$ Statistical significance after correction for multiple comparisons at the level of cluster of contiguous voxels (based on Gaussian random field theory).
$$ Statistical significance after family-wise error (FWE) correction for multiple comparisons at the voxel level.
Abbreviations: NS = non-significant; BA = Brodmann area.
Figure 1 - Areas of significant regional cerebral blood flow (rCBF) reductions in patients with AD relative to healthy controls, using the global normalization
method, are shown in yellow. Foci of significance were overlaid on transaxial brain slices of a structural MRI scan spatially transformed into an approximation
to the Tailarach and Tornoux stereotactic atlas.16 The numbers associated with each frame represent standard coordinates in the z axis. Statistical voxel
values have been thresholded at Z=2.33 (corresponding to p<0.01, uncorrected for multiple comparisons). The brain regions where hypoactivity in the AD
group had been hypothesized a priori, and which showed significant differences between the two groups (at the 0.05 level corrected for multiple comparisons)
were: the left lateral temporal and parietal cortices (labeled respectively with the white-printed letters T and PA) and the posterior cingulate gyrus (PC). The
coordinates of voxels of maximal statistical significance in each cluster, as well as their size, peak Z-scores and associated p values, are provided in Table
1. The figure also shows smaller foci or rCBF reductions in AD patients in the left inferior prefrontal cortex and anterior cingulate gyrus, but these findings
did not retain significance after correction for multiple comparisons.
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cated respectively in: (i) the cerebellum bilaterally (4,541
voxels; maximal Z score = 3.84; coordinates
x,y,z
 of the voxel
of maximal statistical significance = -13; -54; -22; p<0.003
corrected for multiple comparisons at the cluster level); and
(ii) the right pre- and post-central gyri (8,276 voxels; maxi-
mal Z score = 4.53; coordinates
x,y,z
 of the voxel of maxi-
mal statistical significance = 31; -15; 31; p<0.001 corrected
for multiple comparisons at the cluster level, and p=0.041
at the voxel level).
DISCUSSION
In this study, we employed the automated SPM program
to investigate, on a voxel-by-voxel basis, the presence of
between-group rCBF differences using images acquired
with a single-detector SPECT system. To the best of our
knowledge, this is the first study in Brazil that applied
voxel-based analysis methods to process SPECT data ob-
tained using such a conventional and largely available
gamma-camera system. Our comparison of images from a
group of patients with AD relative to healthy controls led
to the identification of rCBF abnormalities in areas that are
broadly consistent with the regions where foci of hypofunc-
tion have been detected in previous PET and SPECT in-
vestigations of subjects with AD, namely the lateral
temporo-parietal cortex and the posterior cingulate cor-
tex.6,20 The relative consistency of our results with such pre-
vious functional imaging literature suggests the feasibility
of applying the SPM program for the analysis of rCBF data
of AD samples obtained using conventional, single-detec-
tor SPECT systems.
Although the findings above are encouraging, it should
be mentioned that our sample included a proportion of AD
patients with moderate or severe dementia. Therefore, one
would have expected the presence of more extensive foci
of cortical hypoactivity in our AD group relative to con-
trols, involving the temporo-parietal cortex more largely
and bilaterally, as well as affecting other regions, such as
the medial temporal region, the precuneus, and the prefron-
tal cortex.6,11,21 This suggests that, due to the lower sensi-
tivity of single-detector SPECT systems,22 the magnitude
of rCBF deficits in a given sample may be underestimated
when the SPM program is used to analyze data acquired
with such a type of SPECT equipment. However, this pos-
sibility could not be directly ascertained in our study, as
we did not obtain rCBF data from the same subjects using
both our single-detector system and another, multiple-de-
tector system affording greater sensitivity and spatial reso-
lution.
Despite the limited sensitivity of single-detector SPECT
scanners, our data suggest that the use of the SPM approach
for the statistical analysis of rCBF data acquired with those
conventional systems may be useful, given the advantages
of the SPM package over ROI-based methods. Among these
advantages is the fact that SPM analyses are performed in
a fully automated fashion, with no observer interference
as in ROI-based or visual inspection methods. Moreover,
SPM analyses are less cumbersome and more reproducible
in comparison with the drawing of small ROIs over sev-
eral sequential slices of the brain. Finally, the voxel-by-
voxel inspection across the entire brain allows the detec-
tion of rCBF abnormalities in deep and medial structures
that are difficult to assess reliably using ROI-based meth-
ods.
As in previous SPECT investigations of AD23, our sta-
tistical parametric map investigating significant rCBF in-
creases in AD patients relative to healthy controls (with
covariance for the total counts in the brain) revealed areas
of hyperactivity in the AD group. Such findings are inter-
preted as artifacts of the statistical analysis;23 because the
brain blood flow in AD patients is reduced in several gray
matter areas, the proportional scaling of individual values
to the total brain uptake leads to an overestimation of the
relative rCBF measures in AD subjects in regions that are
less affected by the disease process, such as the pre-and
post-central gyri and cerebelar regions, all of which show
as hyperactive in our AD subjects.
There are previous studies in which the SPM approach
was used to perform statistical comparisons of functional
imaging data from a single subject versus a control group
of healthy volunteers, using either PET24 or multiple-de-
tector SPECT systems.25,26 This strategy has opened the pos-
sibility for using the SPM program in routine, single-case
diagnostic applications in Neurology and Psychiatry.24 Our
preliminary results warrant further empirical evaluation as
to whether the SPM program could be a useful clinical tool
to aid in the assessment of single subjects imaged with one-
detector SPECT systems, largely available in routine nu-
clear medicine services in Brazil. However, it is important
to highlight that the manipulation of the SPM package de-
mands basic knowledge about image processing methods
and routines of the MATLAB program, and therefore
should be used preferentially under the supervision of
trained computer scientists. The need of such specialized
staff may eventually prevent a more disseminated use of
SPM in nuclear medicine services mainly dedicated to
clinical work.
In conclusion, the results presented herein provide evi-
dence that it is feasible to use the SPM program in rCBF
studies comparing groups of AD patients and healthy sub-
jects studied with conventional, single-detector SPECT sys-
tems. However, our findings were less robust in compari-
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son to results reported in previous investigations of AD us-
ing more sophisticated SPECT systems, suggesting that the
limited sensitivity of single-detector SPECT systems may
underestimate findings of reduced rCBF, even when voxel-
based programs such as SPM are used.
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RESUMO
Duran Fabio LS, Zampieri FG, Bottino CCM, Buchpiguel
CA, Busatto GF. Investigações voxel-a-voxel de anormali-
dades de fluxo sanguíneo cerebral regional na doença de
Alzheimer usando equipamento de SPECT de detector úni-
co. Clinics. 2007;62(4):377-84.
OBJETIVO: Avaliar a viabilidade de emprego do progra-
ma Statistical Parametric Mapping (SPM) para investigar
de forma automatizada, voxel-a-voxel, a presença de
déficits de fluxo sanguíneo cerebral regional (FSCr) em
pacientes com doença de Alzheimer (DA) comparados a
sujeitos-controle pareados para idade, usando imagens de
SPECT adquiridas com um equipamento convencional de
detector único.
MÉTODOS: Foi utilizado um banco de imagens adquiri-
das após injeção de 99mTc-HMPAO em 19 pacientes com
diagnóstico provável de DA e 15 voluntários idosos sau-
dáveis, usando um equipamento de SPECT Orbiter-Siemens
de detector único. Empregando o programa SPM, as ima-
gens foram transformadas espacialmente, suavizadas
(12mm FWHM), e comparadas estatisticamente voxel-a-
voxel entre os dois grupos, usando o teste de T.
RESULTADOS: Foram identificadas reduções significati-
vas de FSCr nos pacientes com DA comparados aos con-
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troles em regiões previstas a priori como afetadas por esta
forma de demência, quais sejam os neocórtices temporal e
parietal em hemisfério esquerdo e o cíngulo posterior di-
reito (p<0,05, corrigido para comparações múltiplas).
DISCUSSÃO: A localização dos focos de redução de FSCr
em pacientes com DA no nosso estudo é, de forma geral,
consistente com os achados de déficits cerebrais detecta-
dos em estudos anteriores de neuroimagem funcional na
DA realizados com equipamentos de resolução espacial
mais alta. Isto sugere o potencial de utilidade do progra-
ma SPM para a análise de dados de SPECT adquiridos com
equipamentos de detector único, apesar da sensibilidade e
resolução espacial limitadas de tais aparelhos.
UNITERMOS: Statistical Parametric Mapping. Demência.
Neuroimagem Funcional. Gama-câmera.
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